One-year data from a large real-world dataset provide reassurance that clinical outcomes with the new-generation LAA occlusion device for stroke prevention compare well with those from pivotal trials.Read More
WRAP-IT Substudies Yield Insights on How to Maximize Value of Antibacterial Envelope for CIEDs
Two new analyses of the landmark trial identify modifiable risk factors for cardiac device infections and quantify the role of an antibiotic envelope in mitigating hematoma-related infection.
App-Based Remote Monitoring of Pacemakers Boosts Transmission Success Rates
The first large multicenter study assessing use of smart devices for direct monitoring of pacemakers and other CIEDs finds improved data transmission success and positive experiences for patients and providers.
Harnessing CT Scans and Machine Learning to Predict Atrial Fibrillation Recurrence
Researchers are combining radiomics and genomics to develop tools to improve the choice of candidates for atrial fibrillation and which areas to ablate.
Integrating Smart Device ECGs Into Practice: A Model May Be at Hand
A pilot study has shown that coupling a smartphone-based ECG device with a cloud-based platform effectively detects post-ablation atrial fibrillation without additional patient or physician burden.
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy
Benefits of CRT Extend to Patients With Severe Left Ventricular Dysfunction
A new study has shown for the first time that cardiac resynchronization therapy yields meaningful improvements in ejection fraction and outcomes even in patients with an LVEF of 15% or less.